HV3 - Module 8

12345678910111213141516
Across
  1. 3. - Chemotherapy phase 3. After induction and consolidation, this recovery can begin. Decrease relapse post treatment.
  2. 4. - Treatment option. --- transplant, or bone marrow transplant, allows for more aggressive chemotherapy than a child could normally tolerate. Allows the body to fight infection again.
  3. 8. - Aetiology of leukaemia. --- genetics is very uncommon, or --- immune system issues.
  4. 11. - Vital to blood clotting and control bleeding. Must transfuse to prevent bleeding and further blood loss as haemoglobin is low.
  5. 13. - Chemotherapy phase 2. Usually more intense, this phase starts once the leukaemia is in remission and lasts for several months.
  6. 15. - Aetiology of leukaemia. --- exposure to CT scans or X-rays in utero.
  7. 16. - Treatment option. --- therapy is when cells are removed from the person’s blood and genetically altered and multiplied in a lab before going back into the blood.
Down
  1. 1. - Oxygen carrying capacity. Must transfuse to maintain oxygen delivery for organ perfusion.
  2. 2. - Aetiology of leukaemia. --- syndromes such as Down Syndrome.
  3. 5. - Treatment option. Targeted therapy - --- is available for children with certain types of ALL, and include Imatinib and Dasatinib.
  4. 6. - Treatment option. --- chemotherapy is given through a lumbar puncture, it is chemo into the cerebrospinal fluid.
  5. 7. - Chemotherapy phase 1. Goal is to achieve remission. Remission is when no leukaemic cells are found in bone marrow, not cured.
  6. 9. - Treatment option. --- therapy uses high energy radiation in high risk patients when other treatment fails.
  7. 10. - Cancer that develops in the bone marrow, in developing blood cells. Results in the uncontrolled growth in WBC, making them immature and unable to develop into functional blood cells.
  8. 12. - Treatment option. --- antibodies, or immunotherapy, are a man-made immune protein used in conjunction with chemotherapy.
  9. 14. - This type of leukaemia is the most common type of cancer in children. Approximately 25% of cancer diagnoses among children under 15.